Acasti Pharma Inc Earning Date (ACST)

USA |NASDAQ |USD |ADR

ACST Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 7, 2022 Dec 2021 - $0.03 $-0.24
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 7, 2022 Dec 2021 - $0.00 $81.00K

Acasti Pharma Inc's next earnings date is Monday, Feb 7, 2022 for the fiscal quarter ending Dec 2021.

ACST Earnings Date & History Chart

ACST Earnings & Revenue Forecast

ACST Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 1 $-0.09 $-0.09 $-0.09

ACST Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 0 / 0 $0.44 $0.44 $0.44

ACST Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 2 $62.33M $16.30M $108.36M

ACST Earnings Date & Revenue History

ACST Earnings History

|
Show More
Show More

ACST Revenue History

|
Show More
Show More

Acasti Pharma Inc Next Earnings Date & Report

ACST Next Earnings Date & Report Preview: Dec 2021 (FQ)

ACST's next earnings date is Monday, Feb 7, 2022 for the fiscal quarter ending Dec 31, 2021.

Acasti Pharma Inc Previous Earnings Dates & Reports

ACST Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Acasti Pharma Inc's previous earnings date was Nov 10, 2021 for its fiscal quarter ended Sep 30, 2021.

ACST's earnings per share (EPS) was $0.03.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -299.33%, and higher than the same period a year before (Sep 2020) by -106.24%.

Revenues were $0.00.

The company reported a net income of $981.00K.

Free cash flow for the quarter was $-6.10M , compared to $-3.40M last quarter and $-4.21M a year before.

ACST ended the quarter with $43.00K in total debt, a decrease of -34.85% compared to the previous quarter.

ACST Previous Earnings Date & Report Recap: Mar 2021 (FY)

Acasti Pharma Inc's previous annual earnings date was Jun 22, 2021 for its fiscal year ended Mar 31, 2021.

ACST's earnings per share (EPS) was $-1.15, missing the consensus analysts forecast of $0.00 by % , and higher than the previous year's EPS (Mar 2020) by -74.41%.

Revenues were $196.00K.

The company reported a net income of $-19.68M.

Acasti Pharma Inc reported a free cash flow of $-14.39M for its fiscal year, compared to $-23.26M a year ago.

The company ended the fiscal year with $86.00K in total debt. lala